Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology EquipmentCell Culture

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1840918

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1840918

3D Cell Culture Market by Product (Scaffolds, Scaffold-free, Microfluidics, Bioprinted), Application, End User, Region - Global Forecast to 2030

PUBLISHED:
PAGES: 323 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global 3D cell culture market is projected to reach USD 2.26 billion by 2030 from USD 1.18 billion in 2024, at a CAGR of 11.7% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsProduct, Application, End User
Regions coveredNorth America, Asia Pacific, Europe, Latin America, Middle East & Africa

Factors such as increased adoption of 3D cell culture and a rise in funding for 3D cell culture research drive market growth.

3D Cell Culture Market - IMG1

The scaffold-based 3D cell culture segment accounted for the highest market share in the product market.

Based on the product, the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. The scaffold-based 3D cell cultures segment accounted for the largest share in 2024. Hydrogels/ECM analogs have emerged as the key contributor to segment growth. Increased demand for hydrogels is raising the focus of key market players on the development and launch of new products in the market. It is also biocompatible and non-toxic, making it ideal for use in research and drug development.

The cancer and stem cell research segment accounted for the largest share of the application market in 2024.

Based on the application, the market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. Cancer & stem cell segment research accounted for the largest market share in 2024. The increasing prevalence of cancer and significant funding initiatives for cancer research from the government and the private sector are major factors driving the growth of this application segment.

The Asia Pacific region is likely to be the fastest-growing regional market.

The 3D cell culture market is segmented into Europe, Asia Pacific, North America, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to be the fastest-growing regional segment during the forecast period. Growth in this market is attributed to the presence of favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing costs, and the growing focus of global market players on emerging Asian countries. The markets for biologics such as antibodies and protein-based drugs are also on the rise in the Asia Pacific region. Biotechnology-based drugs are anticipated to be one of the key drivers for the research industry due to increased research and government funds provided for these drugs. Global pharmaceutical firms are increasingly moving to Asia to tap into its thriving market and lower their production costs by shifting manufacturing to the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Tier 1- 25%, Tier 2- 35%, and Tier 3- 40%
  • By Designation: C-level Executives- 55%, Directors- 20%, and Others- 25%
  • By Region: North America- 45%, Europe- 20%, the Asia Pacific- 20%, Latin America- 10%, the Middle East- 3%, and Africa- 2%

The top players in the global 3D cell culture market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), Tecan Trading AG (Switzerland), Avantor, REPROCELL Inc. (Japan), 3D Biotek LLC. (US), S-BIO, Vaupell Holdings Inc. (US), Advanced BioMatrix Inc. (US), UPM Biomedicals (Finland), SYNTHECON, INCORPORATED (US), Emulate, Inc. (US), CN Bio Innovations Ltd. (UK), Kirkstall Ltd. (UK), Lena Biosciences (US), TissUse GmbH (Germany), Cellendes GmbH (Germany), Greiner Bio-one International GmbH (Germany), AMSBIO (UK), MIMETAS B.V.(Netherlands), and Promocell GmbH (Germany).

Research Coverage

This research report categorizes the 3D cell culture market by product (scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures), application (cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine), end user (pharmaceutical & biotechnology companies, research institutes, cosmetics industry, and other end users) and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the 3D cell culture market. A detailed analysis of the key industry players has been done to provide insights into their business overview, service portfolio, key strategies such as collaborations, partnerships, expansions, agreements, and acquisitions, and recent developments associated with the 3D cell culture market. This report covers a competitive analysis of top players and upcoming startups in the 3D cell culture market ecosystem.

The report's scope covers detailed information regarding the primary factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the 3D cell culture market. A thorough analysis of the key industry players has been conducted to provide insights into their business overview, solutions, and services; key strategies; new product launches, acquisitions, and recent developments associated with the 3D cell culture market. This report covers the competitive analysis of upcoming startups in the 3D cell culture market ecosystem.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

  • Analysis of key drivers (high focus on developing alternatives to animal testing, increasing adoption of personalized medicine, increased government support and funding, rising academia-research collaborations), restraints (high cost of implementing 3D cell culture technologies, lack of widely accepted or single standardization in 3D cell culture), opportunities (emergence of microfluidic based 3D cell culture), and challenges (lack of consistency in 3D cell culture products, high dependency on plastic waste disposals and consumables) influencing the growth of 3D cell culture market.
  • Product Development/Innovation: Detailed insights on newly launched products of the 3D cell culture market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the 3D cell culture market across varied regions.
  • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the 3D cell culture market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), and Avantor Inc. (US), among others
Show more
Product Code: BT 4414

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF STRATEGIC CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources of secondary data
      • 2.1.1.2 Key objectives of secondary research
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Breakdown of primaries
      • 2.1.2.2 Key objectives of primary research
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 GLOBAL MARKET SIZE ESTIMATION
      • 2.2.1.1 Revenue share analysis (bottom-up approach)
      • 2.2.1.2 Secondary data
      • 2.2.1.3 Primary interviews and MnM repository analysis
    • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
    • 2.2.3 SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH)
  • 2.3 GROWTH RATE PROJECTION
  • 2.4 DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

  • 3.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS
  • 3.3 DISRUPTIVE TRENDS SHAPING MARKET
  • 3.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS
  • 3.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

4 PREMIUM INSIGHTS

  • 4.1 UNMET NEEDS AND WHITE SPACES
  • 4.2 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.3 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFTS
  • 4.4 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
  • 4.5 VC/PRIVATE EQUITY INVESTMENT TRENDS AND STARTUP LANDSCAPE
  • 4.6 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 High focus on developing alternatives to animal testing
      • 5.2.1.2 Growing shift toward personalized medicine
      • 5.2.1.3 Integration of microphysiological systems and organ-on-chip platforms
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High costs of implementing 3D cell culture technologies
      • 5.2.2.2 Absence of widely accepted or unified standards for experimental protocols
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High growth opportunities and booming biopharmaceutical sector in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of consistency in scaffold-based 3D cell culture products
      • 5.2.4.2 High dependence on plastic waste disposals and consumables
  • 5.3 TECHNOLOGY ANALYSIS
    • 5.3.1 KEY TECHNOLOGIES
      • 5.3.1.1 Microfluidics
      • 5.3.1.2 Bioprinting
      • 5.3.1.3 Organ-on-chip
    • 5.3.2 COMPLEMENTARY TECHNOLOGIES
      • 5.3.2.1 High-content imaging and automated microscopy
      • 5.3.2.2 High-throughput screening platforms
    • 5.3.3 ADJACENT TECHNOLOGIES
      • 5.3.3.1 Magnetic levitation
      • 5.3.3.2 Microfabrication
  • 5.4 TRADE ANALYSIS
    • 5.4.1 IMPORT DATA
    • 5.4.2 EXPORT DATA
  • 5.5 REGULATORY LANDSCAPE
    • 5.5.1 REGULATORY FRAMEWORK
      • 5.5.1.1 North America
      • 5.5.1.2 Europe
      • 5.5.1.3 Asia Pacific
      • 5.5.1.4 Latin America
      • 5.5.1.5 Middle East & Africa
    • 5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 BARGAINING POWER OF SUPPLIERS
    • 5.6.2 BARGAINING POWER OF BUYERS
    • 5.6.3 THREAT OF NEW ENTRANTS
    • 5.6.4 THREAT OF SUBSTITUTES
    • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 IMPACT OF AI/GENERATIVE AI ON 3D CELL CULTURE MARKET
    • 5.7.1 INTRODUCTION
    • 5.7.2 MARKET POTENTIAL OF AI IN 3D CELL CULTURE APPLICATIONS
    • 5.7.3 AI USE CASES
    • 5.7.4 KEY COMPANIES IMPLEMENTING AI
    • 5.7.5 FUTURE OF GENERATIVE AI IN 3D CELL CULTURE ECOSYSTEM
  • 5.8 IMPACT OF 2025 US TARIFF ON 3D CELL CULTURE MARKET
    • 5.8.1 INTRODUCTION
    • 5.8.2 KEY TARIFF RATES
    • 5.8.3 PRICE IMPACT ANALYSIS
    • 5.8.4 IMPACT ON COUNTRY/REGION
      • 5.8.4.1 US
      • 5.8.4.2 Europe
      • 5.8.4.3 Asia Pacific
    • 5.8.5 IMPACT ON END-USE INDUSTRIES
      • 5.8.5.1 Pharmaceutical and biotech companies
      • 5.8.5.2 Hospitals and diagnostic laboratories
      • 5.8.5.3 Academic and research institutes
      • 5.8.5.4 Contract research organizations & contract development and manufacturing organizations

6 INDUSTRY TRENDS

  • 6.1 PRICING ANALYSIS
    • 6.1.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
    • 6.1.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 6.2 PATENT ANALYSIS
    • 6.2.1 METHODOLOGY
    • 6.2.2 NUMBER OF PATENTS FILED
    • 6.2.3 LIST OF KEY PATENTS
  • 6.3 KEY CONFERENCES AND EVENTS, 2025-2026
  • 6.4 INVESTMENT AND FUNDING SCENARIO
  • 6.5 VALUE CHAIN ANALYSIS
  • 6.6 ECOSYSTEM ANALYSIS
  • 6.7 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 6.7.2 KEY BUYING CRITERIA
  • 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS

7 3D CELL CULTURE MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 SCAFFOLD-BASED 3D CELL CULTURES
    • 7.2.1 HYDROGELS/ECM ANALOGS
      • 7.2.1.1 Hydrogels/ECM analogs to dominate scaffold-based 3D cell culture market during forecast period
    • 7.2.2 SOLID SCAFFOLDS
      • 7.2.2.1 Growing adoption of solid scaffolds in regenerative medicine and preclinical in vitro testing to boost market
    • 7.2.3 MICROPATTERNED SURFACES
      • 7.2.3.1 Ability of micropatterned surfaces to enhance expression of enzyme levels and drug reactivity to drive growth
  • 7.3 SCAFFOLD-FREE 3D CELL CULTURES
    • 7.3.1 LOW-ATTACHMENT PLATES
      • 7.3.1.1 Low-attachment plates to grow at highest rate in scaffold-free 3D cell cultures market
    • 7.3.2 HANGING DROP PLATES
      • 7.3.2.1 Growing use of hanging drop plates in stem cell differentiation and cytotoxicity research to propel growth
    • 7.3.3 3D BIOREACTORS
      • 7.3.3.1 Wide usage of 3D bioreactors in mass production of cells to support market growth
  • 7.4 MICROFLUIDICS-BASED 3D CELL CULTURES
    • 7.4.1 MICROFLUIDICS-BASED 3D CELL CULTURES TO GROW AT HIGHEST RATE IN 3D CELL CULTURE MARKET DURING FORECAST PERIOD
  • 7.5 MAGNETIC & BIOPRINTED 3D CELL CULTURES
    • 7.5.1 GROWING USE OF BIOPRINTING TECHNOLOGIES IN CANCER MODEL CREATION TO BOOST MARKET

8 3D CELL CULTURE MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 CANCER & STEM CELL RESEARCH
    • 8.2.1 INCREASING DEMAND FOR PATIENT-DERIVED, AUTOMATED 3D ORGANOID SYSTEMS TO PROPEL MARKET
  • 8.3 DRUG DISCOVERY & TOXICOLOGY TESTING
    • 8.3.1 REGULATORY DEMAND AND TECHNOLOGICAL MATURATION OF PREDICTIVE 3D TOXICOLOGY MODELS TO DRIVE MARKET GROWTH
  • 8.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE
    • 8.4.1 ADVANCEMENTS IN BIOMATERIAL INNOVATION AND SCAFFOLD CUSTOMIZATION TO BOOST MARKET
  • 8.5 3D CELL CULTURE MARKET, BY MODEL TYPE

9 3D CELL CULTURE MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.2.1 GROWING INTEGRATION OF 3D MODELS BY PHARMA AND BIOTECH COMPANIES TO DRIVE MARKET GROWTH
  • 9.3 RESEARCH INSTITUTES
    • 9.3.1 RESEARCH GRANTS FROM GOVERNMENTAL AND NON-GOVERNMENTAL ORGANIZATIONS TO AUGMENT MARKET
  • 9.4 COSMETICS INDUSTRY
    • 9.4.1 GROWING FOCUS ON DEVELOPING ALTERNATIVES FOR ANIMAL TESTING TO FUEL MARKET
  • 9.5 OTHER END USERS

10 3D CELL CULTURE MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 Product launches and capacity expansions to drive market growth
    • 10.2.3 CANADA
      • 10.2.3.1 Advancements in tissue therapeutics and regenerative medicine to boost market
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Strategic acquisitions to fuel market growth
    • 10.3.3 UK
      • 10.3.3.1 Growing government funding and initiatives to propel market growth
    • 10.3.4 FRANCE
      • 10.3.4.1 Strategic collaborations to propel market growth
    • 10.3.5 ITALY
      • 10.3.5.1 Strong government support to enhance R&D activities
    • 10.3.6 SPAIN
      • 10.3.6.1 Strategic R&D investments and collaborative frameworks to drive market
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 CHINA
      • 10.4.2.1 Rising pharmaceutical R&D and investments to drive market growth
    • 10.4.3 JAPAN
      • 10.4.3.1 Strategic collaborations and technological advancements to augment market
    • 10.4.4 INDIA
      • 10.4.4.1 Strategic collaborations and infrastructure development to support market
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Strategic investments and collaborations to propel market growth
    • 10.4.6 AUSTRALIA
      • 10.4.6.1 Advancements in 3D cell culture technologies to propel market
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Rising prevalence of cancer and therapeutic development to support market
    • 10.5.3 MEXICO
      • 10.5.3.1 Growth in biopharmaceutical market to spur 3D cell culture demand
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST
    • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Saudi Arabia
        • 10.6.2.1.1 Strategic healthcare initiatives to drive market
      • 10.6.2.2 UAE
        • 10.6.2.2.1 Developments in healthcare infrastructure and growing government initiatives to drive market
      • 10.6.2.3 Rest of GCC Countries
    • 10.6.3 REST OF MIDDLE EAST
  • 10.7 AFRICA
    • 10.7.1 STRATEGIC COLLABORATIONS AND HEALTH INITIATIVES TO FUEL MARKET GROWTH
    • 10.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN 3D CELL CULTURE MARKET
  • 11.3 REVENUE ANALYSIS, 2020-2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
    • 11.5.1 COMPANY VALUATION
    • 11.5.2 FINANCIAL METRICS
  • 11.6 BRAND/PRODUCT COMPARISON
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 11.7.5.1 Company footprint
      • 11.7.5.2 Region footprint
      • 11.7.5.3 Product footprint
      • 11.7.5.4 Application footprint
      • 11.7.5.5 End-user footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 11.8.5.1 Detailed list of key startups/SMEs
      • 11.8.5.2 Competitive benchmarking of startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS
    • 11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 THERMO FISHER SCIENTIFIC INC.
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product launches
        • 12.1.1.3.2 Deals
        • 12.1.1.3.3 Expansions
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 MERCK KGAA
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Deals
        • 12.1.2.3.2 Expansions
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses and competitive threats
    • 12.1.3 CORNING INCORPORATED
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 LONZA
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Product launches
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses and competitive threats
    • 12.1.5 AVANTOR, INC.
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
    • 12.1.6 TECAN TRADING AG
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 MnM view
        • 12.1.6.3.1 Key strengths
        • 12.1.6.3.2 Strategic choices
        • 12.1.6.3.3 Weaknesses and competitive threats
    • 12.1.7 REPROCELL INC.
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Deals
    • 12.1.8 3D BIOTEK LLC
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
    • 12.1.9 EMULATE, INC.
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Product launches
    • 12.1.10 SYNTHECON, INCORPORATED
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
    • 12.1.11 INSPHERO
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Deals
        • 12.1.11.3.2 Other developments
    • 12.1.12 KIRKSTALL LTD.
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
    • 12.1.13 GREINER BIO-ONE INTERNATIONAL GMBH
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
    • 12.1.14 PROMOCELL GMBH
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products offered
    • 12.1.15 UPM
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 CN BIO INNOVATIONS LTD.
    • 12.2.2 TISSUSE GMBH
    • 12.2.3 LENA BIOSCIENCES
    • 12.2.4 CELLENDES GMBH
    • 12.2.5 ADVANCED BIOMATRIX, INC. (PART OF BICO)
    • 12.2.6 SYNVIVO, INC.
    • 12.2.7 AMS BIOTECHNOLOGY (EUROPE) LTD
    • 12.2.8 MIMETAS B.V.
    • 12.2.9 S-BIO, VAUPELL HOLDINGS INC.
    • 12.2.10 NANOFIBER SOLUTIONS

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Show more
Product Code: BT 4414

List of Tables

  • TABLE 1 3D CELL CULTURE MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
  • TABLE 3 3D CELL CULTURE MARKET: RISK ANALYSIS
  • TABLE 4 3D CELL CULTURE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 5 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
  • TABLE 6 ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE
  • TABLE 7 IMPORT DATA FOR HS CODE 382100, 2020-2024 (USD THOUSAND)
  • TABLE 8 IMPORT DATA FOR HS CODE 382100, 2020-2024 (TONS)
  • TABLE 9 EXPORT DATA FOR HS CODE 382100, 2020-2024 (USD THOUSAND)
  • TABLE 10 EXPORT DATA FOR HS CODE 382100, 2020-2024 (TONS)
  • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 CELL CULTURE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 17 3D CELL CULTURE PRODUCTS-RELATED TARIFF REVISION
  • TABLE 18 IMPACT ON END-USE APPLICATIONS OF CELL-BASED ASSAY PRODUCTS
  • TABLE 19 AVERAGE SELLING PRICE TREND OF 3D CELL CULTURE PRODUCTS, BY KEY PLAYER, 2022-2024 (USD MILLION)
  • TABLE 20 AVERAGE SELLING PRICE TREND OF EQUIPMENT, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 21 AVERAGE SELLING PRICE TREND OF KITS, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 22 AVERAGE SELLING PRICE TREND OF REAGENTS, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 23 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
  • TABLE 24 LIST OF KEY PATENTS IN 3D CELL CULTURE MARKET, 2023-2025
  • TABLE 25 3D CELL CULTURE MARKET: KEY CONFERENCES AND EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 26 3D CELL CULTURE MARKET: INVESTMENT AND FUNDING SCENARIO OF KEY PLAYERS, 2022-2025
  • TABLE 27 3D CELL CULTURE MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 28 BUYING CRITERIA FOR CELL CULTURE PRODUCTS, BY END USER
  • TABLE 29 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 30 SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 31 SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 32 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 37 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 39 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ ECM ANALOGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 51 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 52 SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 53 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 59 SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 60 SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 61 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 64 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 65 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 66 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 67 SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 69 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 71 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 72 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 73 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 74 SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 75 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 76 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 79 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 80 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 81 SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 83 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 86 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 87 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 88 MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 89 NORTH AMERICA: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 90 EUROPE: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 ASIA PACIFIC: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 92 LATIN AMERICA: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 93 MIDDLE EAST: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 94 GCC COUNTRIES: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 95 MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 96 NORTH AMERICA: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 97 EUROPE: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 ASIA PACIFIC: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 99 LATIN AMERICA: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 100 MIDDLE EAST: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 101 GCC COUNTRIES: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 102 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 103 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 104 NORTH AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 105 EUROPE: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 107 LATIN AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 108 MIDDLE EAST: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 109 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 110 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 111 NORTH AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 112 EUROPE: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 114 LATIN AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 115 MIDDLE EAST: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 116 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 117 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 118 NORTH AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 119 EUROPE: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 121 LATIN AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 122 MIDDLE EAST: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 123 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 124 3D CELL CULTURE MARKET, BY MODEL TYPE, 2023-2030 (USD MILLION)
  • TABLE 125 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 126 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 127 NORTH AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 128 EUROPE: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 130 LATIN AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 131 MIDDLE EAST: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 132 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 133 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 134 NORTH AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 135 EUROPE: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 137 LATIN AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 138 MIDDLE EAST: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 139 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 140 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 141 NORTH AMERICA: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 142 EUROPE: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 144 LATIN AMERICA: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 145 MIDDLE EAST: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 146 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 147 3D CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 148 NORTH AMERICA: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 149 EUROPE: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 151 LATIN AMERICA: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 152 MIDDLE EAST: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 153 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 154 3D CELL CULTURE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 155 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 156 NORTH AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 157 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 158 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 159 NORTH AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 160 NORTH AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 161 US: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 162 US: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 163 US: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 164 US: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 165 US: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 166 CANADA: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 167 CANADA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 168 CANADA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 CANADA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 170 CANADA: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 171 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 172 EUROPE: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 173 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 174 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 175 EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 176 EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 177 GERMANY: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 178 GERMANY: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 179 GERMANY: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 180 GERMANY: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 181 GERMANY: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 182 UK: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 183 UK: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 184 UK: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 185 UK: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 186 UK: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 187 FRANCE: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 188 FRANCE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 189 FRANCE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 190 FRANCE: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 191 FRANCE: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 192 ITALY: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 193 ITALY: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 194 ITALY: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 195 ITALY: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 196 ITALY: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 197 SPAIN: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 198 SPAIN: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 199 SPAIN: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 200 SPAIN: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 201 SPAIN: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 202 REST OF EUROPE: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 203 REST OF EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 REST OF EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 205 REST OF EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 206 REST OF EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 207 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 209 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 211 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 213 CHINA: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 214 CHINA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 215 CHINA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 216 CHINA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 217 CHINA: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 218 JAPAN: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 219 JAPAN: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 220 JAPAN: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 221 JAPAN: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 222 JAPAN: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 223 INDIA: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 224 INDIA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 225 INDIA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 226 INDIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 227 INDIA: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 228 SOUTH KOREA: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 229 SOUTH KOREA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 230 SOUTH KOREA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 231 SOUTH KOREA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 232 SOUTH KOREA: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 233 AUSTRALIA: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 234 AUSTRALIA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 235 AUSTRALIA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 236 AUSTRALIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 237 AUSTRALIA: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 238 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 239 REST OF ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 240 REST OF ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 241 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 242 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 243 LATIN AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 244 LATIN AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 245 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 246 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 247 LATIN AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 248 LATIN AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 249 BRAZIL: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 250 BRAZIL: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 251 BRAZIL: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 252 BRAZIL: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 253 BRAZIL: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 254 MEXICO: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 MEXICO: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 256 MEXICO: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 257 MEXICO: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 258 MEXICO: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 259 REST OF LATIN AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 260 REST OF LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 261 REST OF LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 262 REST OF LATIN AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 263 REST OF LATIN AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 264 MIDDLE EAST: 3D CELL CULTURE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 265 MIDDLE EAST: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 266 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 267 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 268 MIDDLE EAST: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 269 MIDDLE EAST: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 270 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 271 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 272 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 273 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 274 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 275 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 276 SAUDI ARABIA: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 277 SAUDI ARABIA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 278 SAUDI ARABIA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 279 SAUDI ARABIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 280 SAUDI ARABIA: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 281 UAE: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 282 UAE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 283 UAE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 284 UAE: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 285 UAE: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 286 REST OF GCC COUNTRIES: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 287 REST OF GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 288 REST OF GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 289 REST OF GCC COUNTRIES: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 290 REST OF GCC COUNTRIES: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 291 REST OF MIDDLE EAST: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 292 REST OF MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 293 REST OF MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 294 REST OF MIDDLE EAST: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 295 REST OF MIDDLE EAST: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 296 AFRICA: 3D CELL CULTURE MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 297 AFRICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 298 AFRICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 299 AFRICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 300 AFRICA: 3D CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 301 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL CULTURE MARKET, JANUARY 2022-SEPTEMBER 2025
  • TABLE 302 3D CELL CULTURE MARKET: DEGREE OF COMPETITION
  • TABLE 303 3D CELL CULTURE MARKET: REGION FOOTPRINT
  • TABLE 304 3D CELL CULTURE MARKET: PRODUCT FOOTPRINT
  • TABLE 305 3D CELL CULTURE MARKET: APPLICATION FOOTPRINT
  • TABLE 306 3D CELL CULTURE MARKET: END-USER FOOTPRINT
  • TABLE 307 3D CELL CULTURE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 308 3D CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 309 3D CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 310 3D CELL CULTURE MARKET: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 311 3D CELL CULTURE MARKET: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 312 3D CELL CULTURE MARKET: OTHER DEVELOPMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 313 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 314 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 315 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 316 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 317 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 318 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 319 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 320 MERCK KGAA: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 321 MERCK KGAA: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 322 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 323 CORNING INCORPORATED: PRODUCTS OFFERED
  • TABLE 324 CORNING INCORPORATED: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 325 LONZA: COMPANY OVERVIEW
  • TABLE 326 LONZA: PRODUCTS OFFERED
  • TABLE 327 LONZA: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 328 AVANTOR, INC.: COMPANY OVERVIEW
  • TABLE 329 AVANTOR, INC.: PRODUCTS OFFERED
  • TABLE 330 TECAN TRADING AG: COMPANY OVERVIEW
  • TABLE 331 TECAN TRADING AG: PRODUCTS OFFERED
  • TABLE 332 REPROCELL INC.: COMPANY OVERVIEW
  • TABLE 333 REPROCELL INC.: PRODUCTS OFFERED
  • TABLE 334 REPROCELL INC.: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 335 3D BIOTEK LLC: COMPANY OVERVIEW
  • TABLE 336 3D BIOTEK LLC: PRODUCTS OFFERED
  • TABLE 337 EMULATE, INC.: COMPANY OVERVIEW
  • TABLE 338 EMULATE, INC.: PRODUCTS OFFERED
  • TABLE 339 EMULATE, INC.: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 340 SYNTHECON, INCORPORATED: COMPANY OVERVIEW
  • TABLE 341 SYNTHECON, INCORPORATED: PRODUCTS OFFERED
  • TABLE 342 INSPHERO: COMPANY OVERVIEW
  • TABLE 343 INSPHERO: PRODUCTS OFFERED
  • TABLE 344 INSPHERO: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 345 INSPHERO: OTHER DEVELOPMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 346 KIRKSTALL LTD.: COMPANY OVERVIEW
  • TABLE 347 KIRKSTALL LTD.: PRODUCTS OFFERED
  • TABLE 348 GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY OVERVIEW
  • TABLE 349 GREINER BIO-ONE INTERNATIONAL GMBH: PRODUCTS OFFERED
  • TABLE 350 PROMOCELL GMBH: COMPANY OVERVIEW
  • TABLE 351 PROMOCELL GMBH: PRODUCTS OFFERED
  • TABLE 352 UPM: COMPANY OVERVIEW
  • TABLE 353 UPM: PRODUCTS OFFERED
  • TABLE 354 CN BIO INNOVATIONS LTD.: COMPANY OVERVIEW
  • TABLE 355 TISSUSE GMBH: COMPANY OVERVIEW
  • TABLE 356 LENA BIOSCIENCES: COMPANY OVERVIEW
  • TABLE 357 CELLENDES GMBH: COMPANY OVERVIEW
  • TABLE 358 ADVANCED BIOMATRIX, INC.: COMPANY OVERVIEW
  • TABLE 359 SYNVIVO, INC.: COMPANY OVERVIEW
  • TABLE 360 AMS BIOTECHNOLOGY (EUROPE) LTD: COMPANY OVERVIEW
  • TABLE 361 MIMETAS B.V.: COMPANY OVERVIEW
  • TABLE 362 S-BIO, VAUPELL HOLDINGS INC.: COMPANY OVERVIEW
  • TABLE 363 NANOFIBER SOLUTIONS: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 3D CELL CULTURE MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 3D CELL CULTURE MARKET: RESEARCH DESIGN
  • FIGURE 3 3D CELL CULTURE MARKET: BREAKDOWN OF PRIMARIES (SUPPLY- AND DEMAND-SIDE PARTICIPANTS)
  • FIGURE 4 3D CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
  • FIGURE 5 3D CELL CULTURE MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH), 2024
  • FIGURE 6 COMPANY REVENUE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC., 2024
  • FIGURE 7 3D CELL CULTURE MARKET: INSIGHTS FROM PRIMARY EXPERTS
  • FIGURE 8 3D CELL CULTURE SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 9 3D CELL CULTURE MARKET: CAGR PROJECTIONS
  • FIGURE 10 3D CELL CULTURE MARKET: DATA TRIANGULATION
  • FIGURE 11 3D CELL CULTURE MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 3D CELL CULTURE MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 3D CELL CULTURE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 HIGH FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING TO DRIVE MARKET
  • FIGURE 15 3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16 3D CELL CULTURE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 17 AI USE CASES
  • FIGURE 18 AVERAGE SELLING PRICE OF EQUIPMENT, BY KEY PLAYER, 2024 (USD)
  • FIGURE 19 AVERAGE SELLING PRICE OF KITS, BY KEY PLAYER, 2024 (USD)
  • FIGURE 20 AVERAGE SELLING PRICE OF REAGENTS, BY KEY PLAYER, 2024 (USD)
  • FIGURE 21 AVERAGE SELLING PRICE OF EQUIPMENT, BY REGION, 2024 (USD MILLION)
  • FIGURE 22 AVERAGE SELLING PRICE OF KITS, BY REGION, 2024 (USD MILLION)
  • FIGURE 23 AVERAGE SELLING PRICE OF REAGENTS, BY REGION, 2024 (USD MILLION)
  • FIGURE 24 3D CELL CULTURE MARKET: PATENT ANALYSIS, JANUARY 2014-DECEMBER 2024
  • FIGURE 25 3D CELL CULTURE MARKET: INVESTMENT AND FUNDING SCENARIO, 2022-2025 (USD MILLION)
  • FIGURE 26 3D CELL CULTURE MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 27 3D CELL CULTURE MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF 3D CELL CULTURE PRODUCTS
  • FIGURE 29 KEY BUYING CRITERIA, BY END USER
  • FIGURE 30 NEW REVENUE POCKETS FOR PLAYERS IN 3D CELL CULTURE MARKET
  • FIGURE 31 NORTH AMERICA: 3D CELL CULTURE MARKET SNAPSHOT
  • FIGURE 32 ASIA PACIFIC: 3D CELL CULTURE MARKET SNAPSHOT
  • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN 3D CELL CULTURE MARKET, 2020-2024 (USD MILLION)
  • FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN 3D CELL CULTURE MARKET, 2024
  • FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 36 EV/EBITDA OF KEY VENDORS
  • FIGURE 37 3D CELL CULTURE MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 38 3D CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 39 3D CELL CULTURE MARKET: COMPANY FOOTPRINT
  • FIGURE 40 3D CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2024)
  • FIGURE 43 CORNING INCORPORATED: COMPANY SNAPSHOT (2024)
  • FIGURE 44 LONZA: COMPANY SNAPSHOT (2024)
  • FIGURE 45 AVANTOR, INC: COMPANY SNAPSHOT (2024)
  • FIGURE 46 TECAN TRADING AG: COMPANY SNAPSHOT (2024)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!